130 filings
Page 4 of 7
8-K
6wei7
12 Nov 20
Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results
4:11pm
8-K
1o5l1wm4qb5b
14 Sep 20
Regulation FD Disclosure
8:00am
8-K
fes6bcywl9m
1 Sep 20
Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:12pm
8-K
0qu1u1c6qej
11 Aug 20
Sun BioPharma, Inc. Provides Business Update and Reports Q2 2020 Financial Results
8:15am
8-K
p2o omg1c4c
16 Jul 20
Sun BioPharma, Inc. Appoints Jennifer K. Simpson, Ph.D., as President and CEO
8:02am
8-K
23bpbu437q8
30 Jun 20
Sun BioPharma, Inc. Receives FDA Fast Track Designation for SBP-101
4:16pm
8-K
44hsw
19 Jun 20
Entry into a Material Definitive Agreement
8:00am
8-K
anrw3us7lkuyci7svet6
11 Jun 20
Entry into a Material Definitive Agreement
4:16pm
8-K
6cy7oss2
26 May 20
Departure of Directors or Certain Officers
11:47am
8-K
l2o93jahj
12 May 20
Sun BioPharma, Inc. Provides a Business Update and Reports Q1 2020 Financial Results
4:30pm
8-K
mdo26tmv6u9 xrz
3 Apr 20
Sun BioPharma Announces Pause in Enrollment of Clinical Trial of
4:47pm
8-K
3ido5ehqj5letv
24 Mar 20
Sun BioPharma Provides Business Update and Reports Operating Results for FY2019
8:19am
8-K
ilzaf
28 Jan 20
Departure of Directors or Certain Officers
8:30am
8-K
ru27rzv90c58
24 Jan 20
Sun BioPharma, Inc. Summarizes SBP-101 Phase 1 Clinical Data Presented at ASCO 2020 Annual Gastrointestinal Cancers Symposium
3:00pm
8-K
zwbexh8z9f24 4b
20 Dec 19
Departure of Directors or Certain Officers
9:00am
8-K
gk61 faj9ol90b3
13 Nov 19
Sun BioPharma, Inc. Provides a Business Update and Reports Q3 2019 Financial Results
8:15am
8-K
rtzzml6z9gl5 xsmti
9 Oct 19
Entry into a Material Definitive Agreement
4:15pm
8-K
m5i1l2oxb u8
25 Sep 19
Entry into a Material Definitive Agreement
9:30am
8-K
mvx5qyi
6 Sep 19
Entry into a Material Definitive Agreement
4:17pm
8-K
xr0oecxwlq4oxfle
29 Aug 19
Entry into a Material Definitive Agreement
5:03pm